Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor and shock.

G Feuerstein1, A L Siren

  • 1Uniformed Services University of the Health Science, Department of Neurology, Bethesda, Md.

Progress in Biochemical Pharmacology
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of thyrotropin-releasing hormone on lipoxygenase-induced hypotension in the unanesthetized Guinea pig.

Pharmaceutical research·2013
Same author

Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours.

British journal of cancer·2011
Same author

Apoptosis and congestive heart failure.

Trends in cardiovascular medicine·2011
Same author

Increased erythropoietin production after myocardial infarction in mice.

Heart (British Cardiac Society)·2006
Same author

Expression patterns of erythropoietin and its receptor in the developing midbrain.

Anatomy and embryology·2004
Same author

Bioethics and antibioethics in Germany: a sociological approach.

Journal international de bioethique = International journal of bioethics·2002
Same journal

Dietary fiber research.

Progress in biochemical pharmacology·1990
Same journal

Biologically active ether lipids.

Progress in biochemical pharmacology·1988
Same journal

Effect of changes in intracellular pH on the contractility of rat resistance vessels.

Progress in biochemical pharmacology·1988
Same journal

Vasoreactive effects of hypothalamic sodium transport inhibitor.

Progress in biochemical pharmacology·1988
Same journal

Platelet-activating factor and the cardiovascular system: involvement in cardiac anaphylaxis.

Progress in biochemical pharmacology·1988
Same journal

Synthesis of biologically active ether lipids.

Progress in biochemical pharmacology·1988
See all related articles

Platelet-activating factor (PAF) is a potent lipid mediator that can cause shock, organ damage, and death. Understanding PAF

Area of Science:

  • Biochemistry and Pharmacology
  • Pathophysiology of Shock States

Background:

  • Platelet-activating factor (PAF) is a potent vasoactive lipid implicated in various pathophysiological processes.
  • PAF actions can lead to inadequate organ perfusion, irreversible damage, and death, particularly affecting the heart, pulmonary vessels, and microcirculation.

Purpose of the Study:

  • To highlight the major components of PAF actions leading to shock.
  • To discuss the role of PAF in shock states and potential therapeutic strategies.
  • To review evidence for PAF's involvement in conditions like anaphylaxis and endotoxemia.

Main Methods:

  • Review of existing literature on PAF actions and its role in shock.
  • Analysis of data from studies involving PAF antagonists and other therapeutic interventions.

Related Experiment Videos

  • Examination of evidence for PAF production in various pathophysiological processes.

    • Main Results:

    • PAF induces hypotension, potentially exacerbating organ dysfunction through effects on pulmonary airways and promoting thrombi formation.
    • PAF-induced shock and death can be prevented by both PAF antagonists and non-PAF antagonist drugs, such as dexamethasone.
    • Limited direct proof exists for PAF production in shock states beyond anaphylaxis and endotoxemia.

    Conclusions:

    • PAF is a significant mediator capable of causing severe biological derangements and death.
    • While its role in anaphylaxis and endotoxemia is supported, further investigation is needed for other shock conditions.
    • Pharmacological interventions activating physiological mechanisms may reverse PAF-induced pathological processes.